Onkologie und Hämatologie | Zeitschrift memo - Magazine of European Medical Oncology Ausgabe 3/2022 share TEILEN Suchen insite SUCHEN Inhaltsverzeichnis (19 Artikel) 01.09.2022 | editorial CAR-T cells—Real-time experience applying CAR-T cells—What we have learned so far Univ.-Prof. Dr. Hildegard Greinix 01.09.2022 | editorial Molecular profiling leading to personalized cancer treatment Ap. Prof. PDin Dr.in med.univ.et Dr.in scient. med. Barbara Kiesewetter 01.09.2022 | editorial Neoadjuvant treatment for solid tumors—the earlier, the better Univ.-Prof. Dr. Rupert Bartsch, Prof. Dr. Wolfgang Hilbe 19.07.2022 | short review Real time experience applying CAR T-cells for B-cell lymphoma—What we have learned so far: Acute toxicity management Dr. Emine Kaynak, Dr. Johannes Clausen 17.08.2022 | short review CAR T cells in multiple myeloma: Where we stand and where we might be going PD Dr. Niklas Zojer, Dr. Martin Schreder, Univ.-Prof. Dr. Heinz Ludwig Open Access 13.04.2022 | review Applicability of ESMO-MCBS and ESCAT for molecular tumor boards Dr.med.univ. Ladislaia Wolff, Ap. Prof. PD Dr. Dr. Barbara Kiesewetter PDF-Version jetzt herunterladen Zum Volltext Open Access 15.02.2022 | short review Molecular profiling leading to personalized treatment in breast cancer Dr. med. univ. Eva Valentina Klocker, Assoz. Prof. PD Dr. med. univ. et scient. med. Marija Balic, Univ.-Prof. Dr. Günther Steger PDF-Version jetzt herunterladen Zum Volltext Open Access 19.07.2022 | short review Molecular profiling in lung cancer Laurenz Nagl, Georg Pall, Dominik Wolf, Andreas Pircher, Lena Horvath PDF-Version jetzt herunterladen Zum Volltext 29.08.2022 | short review Molecular profiling in colorectal cancer Gudrun Piringer Msc 19.07.2022 | short review Neoadjuvant treatment in gastric cancer Bettina Sonnweber, Marc Schaber, Ewald Wöll MD Open Access 24.08.2022 | short review Neoadjuvant treatment in non-small-cell lung cancer—the earlier, the better Angelika Terbuch, Gudrun Absenger PDF-Version jetzt herunterladen Zum Volltext 10.08.2022 | short review Neoadjuvant treatment of pancreatic ductal adenocarcinoma Katharina Kosma, Sabine Thalhammer, Thomas Gruenberger 06.07.2022 | short review Neoadjuvant treatment in solid tumors—the earlier, the better in breast cancer Dr. Renate Pusch 08.06.2021 | case report Breast implant-associated anaplastic large-cell lymphoma: a European case report and literature review Federico Ghidinelli M.D., Luigi Filippini M.D., Paola Porsio M.D., Federico Canzi M.D., Rino Balzano M.D., Elisa Flocchini M.D., Anna Bianchi M.D. 11.07.2022 | comment Breast implant-associated anaplastic large-cell lymphoma—update on challenges, advances and opportunities Andreas Pircher MD PhD, Roberto N. Miranda 09.05.2022 | short review Essential news and practice changing trials in oesophageal, gastroesophageal junction and gastric cancer in 2021 Patrick Reimann, Thomas Winder 19.07.2022 | case report Multiple myeloma with central nervous system relapse: a case report Petra Marics, Wolfgang Pokieser, Nikolaus Neubauer, Georg Slavka, Wolfgang Hilbe, Martin Schreder 25.08.2022 | original report Systemic inflammatory response index is a prognostic biomarker in unresectable pancreatic adenocarcinoma and identifies patients for more intensive treatment Sara Dâmaso MD, Rita Paiva MD, Inês Pinho MD, Miguel Esperança-Martins MD, Raquel Lopes Brás MD, Cecília Melo Alvim MD, António Quintela MD, Ana Lúcia Costa MD, Luís Costa MD Open Access 17.08.2022 | Publisher Correction Publisher Correction: Brain metastases: new systemic treatment approaches Ariane Steindl MD PhD, Anna Sophie Berghoff PDF-Version jetzt herunterladen Zum Volltext
